FGD3 and breast cancer: Concerning the setting of the cut-off for the analysis of FGD3 expression by IHC, we used the same criteria that were utilized in a previous study from our group that analyzed the expression of this gene in a series of young women with breast cancer [10]; a similar approach was used also by Willis et al. [9].